MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 128 filers reported holding MYOKARDIA INC in Q3 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,826,000 | +13.2% | 13,400 | -19.8% | 0.01% | +14.3% |
Q2 2020 | $1,613,000 | +683.0% | 16,700 | +279.5% | 0.01% | +600.0% |
Q1 2020 | $206,000 | -14.2% | 4,400 | +33.3% | 0.00% | 0.0% |
Q4 2019 | $240,000 | -14.3% | 3,300 | -38.9% | 0.00% | 0.0% |
Q3 2019 | $280,000 | +1020.0% | 5,400 | +980.0% | 0.00% | – |
Q2 2019 | $25,000 | -97.3% | 500 | -97.2% | 0.00% | -100.0% |
Q1 2019 | $935,000 | +3.5% | 18,000 | -2.7% | 0.00% | -20.0% |
Q4 2018 | $903,000 | -25.1% | 18,500 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $1,206,000 | +7.5% | 18,500 | -18.1% | 0.01% | 0.0% |
Q2 2018 | $1,122,000 | +27.8% | 22,600 | +25.6% | 0.01% | +25.0% |
Q1 2018 | $878,000 | -3.0% | 18,000 | -16.3% | 0.00% | 0.0% |
Q4 2017 | $905,000 | +21.5% | 21,500 | +23.6% | 0.00% | +33.3% |
Q3 2017 | $745,000 | – | 17,400 | – | 0.00% | – |
Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2016 | $46,000 | -20.7% | 3,600 | 0.0% | 0.00% | – |
Q3 2016 | $58,000 | +28.9% | 3,600 | -2.7% | 0.00% | – |
Q2 2016 | $45,000 | +114.3% | 3,700 | +85.0% | 0.00% | – |
Q1 2016 | $21,000 | -27.6% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $29,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
Grace Capital | 23,400 | $3,190,000 | 2.47% |